QIM
ANIK icon

Quantitative Investment Management’s Anika Therapeutics ANIK Stock Holding History

Quantitative Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,000
Closed -$539K – 729
2017
Q4 		$539K Buy
10,000
+1,300
+15% +$72K 0.01% 661
2017
Q3 		$504K Buy
+8,700
New +$455K 0.01% 608
2016
Q4 		– Sell
-5,700
Closed -$272K – 775
2016
Q3 		$272K Sell
5,700
-1,000
-15% -$49.4K 0.01% 604
2016
Q2 		$359K Buy
6,700
+1,800
+37% +$84.8K 0.02% 601
2016
Q1 		$219K Buy
+4,900
New +$199K 0.01% 681

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Quantitative Investment Management's ANIK Position: Q1 2018 in Review

Quantitative Investment Management sold out of Anika Therapeutics (ANIK) in Q1 2018, closing a stake of 10,000 shares — an estimated $539K sold.

Quantitative Investment Management first reported a position in ANIK in Q1 2016 and held it in 5 quarters. The position peaked at $539K in Q4 2017. 170 funds tracked by Wall St. Rank hold ANIK as of Q1 2018.

  • Quantitative Investment Management reported no remaining Anika Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 10,000 Anika Therapeutics shares in Q1 2018, an estimated $539K.
  • Quantitative Investment Management first reported a position in Anika Therapeutics in Q1 2016 and held it in 5 quarters.
  • Quantitative Investment Management's Anika Therapeutics position peaked at $539K in Q4 2017.
  • 170 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2018.

Based on Quantitative Investment Management's 13F filing for Q1 2018, filed 15 May 2018.